No Data
No Data
No Data
No Data
No Data
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,
GlobeNewswireMar 25 20:50
Buy Rating Affirmed: Anticipating Alpha Tau Medical's Clinical Milestones and Growth Potential in 2024
TipRanksMar 13 00:25
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.
BenzingaMar 13 00:19
Alpha Tau Medical Price Target Cut to $7.00/Share From $8.00 by Piper Sandler
Alpha Tau Medical Price Target Cut to $7.00/Share From $8.00 by Piper Sandler
Dow JonesMar 8 23:01
Piper Sandler Reiterates Overweight on Alpha Tau Medical, Lowers Price Target to $7
Piper Sandler analyst Jason Bednar reiterates Alpha Tau Medical with a Overweight and lowers the price target from $8 to $7.
Analyst UpgradesMar 8 22:51
Alpha Tau Medical Ltd (DRTS) Gets a Buy From Piper Sandler
TipRanksMar 8 20:47
No Data
No Data